Global Statins Market Report By Type (Natural & Synthetic), By Therapeutic Area (Cardiovascular Disorders, Obesity, Inflammatory Disorders, and Others), By Drug Class (Atorvastatin, Fluvastatin, Lovastatin, Pravastatin, Simvastatin, and Others), By Application (Dyslipidemia and Other), By Distribution (Hospitals, Clinics And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11212244
May 2020
Report Formats:

The global demand for Statins Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020-2026.
 
The Statins are  HMG-CoA reductase inhibitors, a class of lipid lessening medications that reduce poor health and other risks in those who are prone to cardiovascular diseases. They are the most widely used cholesterol lowering drugs.  Low density Lipoproteins (LDL), are responsible for the growth of atherosclerosis and coronary heart diseases. Statins are effective against the LDL Cholesterol that result in cardiovascular diseases.
 
Market Dynamics
 
The rapid urbanization is leading the mankind towards a fast paced life. This is resulting in adaption of junk food and ready to eat food which substantially is increasing the rate of heart diseases in population. Additionally, government initiatives like cholesterol awareness campaigns and technological advancement in the healthcare facilities is boosting the market. However, the side effects of statins on human body is the likely to restrain the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each type, therapeutic area, drug class, applications and distribution segment in the global market of statins.
 
Market Segmentation
 
The entire statins market has been sub-categorized into type, therapeutic area, drug class, applications and distribution. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Type

  • Natural Statins
  • Synthetic Statins
 
By Therapeutic Area
  • Cardiovascular Disorders
  • Obesity
  • Inflammatory Disorders
  • Others
 
By Drug Class
  • Atorvastatin
  • Fluvastatin
  • Lovastatin
  • Pravastatin
  • Simvastatin
  • Others

By Applications
  • Dyslipidemia
  • Others
 
By Distribution Channel
  • Hospitals
  • Clinics
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for Statins market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Statins Market By Revenue (USD MN)
 


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Statins market include Abbott Laboratories, AstraZeneca, Aurobindo Pharma, Biocon, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, etc., and Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.   

METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Statins Market
       2.2. Global Statins Market Snapshot
 
3 . STATINS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Statins Market
       3.3. Market Restraints of Statins Market
       3.4. Opportunities of Statins Market
       3.5. Trends of Statins Market
       3.6. Porter’s Five Force Analysis of Statins Market
       3.7. Statins Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Therapeutic Area
           3.7.3 Market Attractive Analysis by Drug Class
           3.7.4 Market Attractive Analysis by Applications
           3.7.5 Market Attractive Analysis by Distribution Channel
           3.7.6 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Statins Value Chain Analysis
       4.2. Statins Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Statins Raw Material Manufactures List
           4.2.3. Price Trend of Statins Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Statins Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Statins Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Statins Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Statins Market
 
6 . GLOBAL STATINS MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Global Statins Market Analysis by Type
       6.3 Market Analysis of Natural Statins by Regions
       6.4 Market Analysis of Synthetic Statins by Regions
 
7 . GLOBAL STATINS MARKET ANALYSIS BY THERAPEUTIC AREA
       7.1 Overview by Therapeutic Area
       7.2 Global Statins Market Analysis by Therapeutic Area
       7.3 Market Analysis of Cardiovascular Disorders by Regions
       7.4 Market Analysis of Obesity by Regions
       7.5 Market Analysis of Inflammatory Disorders by Regions
       7.6 Market Analysis of Others by Regions
 
8 . GLOBAL STATINS MARKET ANALYSIS BY DRUG CLASS
       8.1 Overview by Drug Class
       8.2 Global Statins Market Analysis by Drug Class
       8.3 Market Analysis of Atorvastatin by Regions
       8.4 Market Analysis of Fluvastatin by Regions
       8.5 Market Analysis of Lovastatin by Regions
       8.6 Market Analysis of Pravastatin by Regions
       8.7 Market Analysis of Simvastatin by Regions
       8.8 Market Analysis of Others by Regions
 
9 . GLOBAL STATINS MARKET ANALYSIS BY APPLICATIONS
       9.1 Overview by Applications
       9.2 Global Statins Market Analysis by Applications
       9.3 Market Analysis of Dyslipidemia by Regions
       9.4 Market Analysis of Others by Regions
 
10 . GLOBAL STATINS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       10.1 Overview by Distribution Channel
       10.2 Global Statins Market Analysis by Distribution Channel
       10.3 Market Analysis of Hospitals by Regions
       10.4 Market Analysis of Clinics by Regions
       10.5 Market Analysis of Others by Regions
 
11 . GLOBAL STATINS MARKET ANALYSIS BY GEOGRAPHY
       11.1. Regional Outlook
       11.2. Introduction
       11.3. North America
           11.3.1. Overview
           11.3.2. North America Statins Market Estimate by Country
           11.3.3. United State
           11.3.4. Rest of North America
       11.4. Europe
           11.4.1. Overview
           11.4.2. Europe Statins Market Estimate by Market Segment
           11.4.3. Europe Statins Market Estimate by Country
           11.4.4. United Kingdom
           11.4.5. France
           11.4.6. Germany
           11.4.7 Rest of Europe
       11.5. Asia Pacific
           11.5.1. Overview
           11.5.2. Asia Pacific Statins Market Estimate by Market Segment
           11.5.3. Asia Pacific Statins Market Estimate by Country
           11.5.4. China
           11.5.5. Japan
           11.5.6. India
           11.5.7. Rest of Asia Pacific
       11.6. Latin America
           11.6.1. Overview
           11.6.2. Latin America Statins Market Estimate by Market Segment
           11.6.3. Latin America Statins Market Estimate by Country
           11.6.4. Brazil
           11.6.5. Rest of Latin America
       11.7. Middle East & Africa
           11.7.1. Overview
           11.7.2. Middle East & Africa Statins Market Estimate by Market Segment
           11.7.3. Middle East & Africa Statins Market Estimate by Country
           11.7.4. Middle East
           11.7.5. Africa
 
12 COMPETITIVE LANDSCAPE OF THE STATINS COMPANIES
       12.1. Statins Market Competition
       12.2. Partnership/Collaboration/Agreement
       12.3. Merger And Acquisitions
       12.4. New Product Launch
       12.5. Other Developments
 
13 COMPANY PROFILES OF STATINS INDUSTRY
       13.1. Company Share Analysis
       13.2. Market Concentration Rate
       13.3. Abbott Laboratories
           13.3.1. Company Overview
           13.3.2. Financials
           13.3.3. Products
           13.3.4. Recent Developments
       13.4. AstraZeneca
           13.4.1. Company Overview
           13.4.2. Financials
           13.4.3. Products
           13.4.4. Recent Developments
       13.5. Aurobindo Pharma
           13.5.1. Company Overview
           13.5.2. Financials
           13.5.3. Products
           13.5.4. Recent Developments
       13.6. Biocon
           13.6.1. Company Overview
           13.6.2. Financials
           13.6.3. Products
           13.6.4. Recent Developments
       13.7. GlaxoSmithKline
           13.7.1. Company Overview
           13.7.2. Financials
           13.7.3. Products
           13.7.4. Recent Developments
       13.8. Merck & Co.
           13.8.1. Company Overview
           13.8.2. Financials
           13.8.3. Products
           13.8.4. Recent Developments
       13.9. Novartis
           13.9.1. Company Overview
           13.9.2. Financials
           13.9.3. Products
           13.9.4. Recent Developments
       13.10. Pfizer
           13.10.1. Company Overview
           13.10.2. Financials
           13.10.3. Products
           13.10.4. Recent Developments
       13.11. Others
           13.11.1. Company Overview
           13.11.2. Financials
           13.11.3. Products
           13.11.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Statins Market Snapshot
  • Drivers of The Global Statins Market Impact Analysis
  • Restraints of The Global Statins Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Statins Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Statins Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Statins Market
  • Global Statins Market Analysis by Type (USD MN)
  • Global Statins Market Analysis in Natural Statins by Geography (USD MN)
  • Global Statins Market Analysis in Synthetic Statins by Geography (USD MN)
  • Global Statins Market Analysis by Therapeutic Area (USD MN)
  • Global Statins Market Analysis in Cardiovascular Disorders by Geography (USD MN)
  • Global Statins Market Analysis in Obesity by Geography (USD MN)
  • Global Statins Market Analysis in Inflammatory Disorders by Geography (USD MN)
  • Global Statins Market Analysis in Others by Geography (USD MN)
  • Global Statins Market Analysis by Drug Class (USD MN)
  • Global Statins Market Analysis in Atorvastatin by Geography (USD MN)
  • Global Statins Market Analysis in Fluvastatin by Geography (USD MN)
  • Global Statins Market Analysis in Lovastatin by Geography (USD MN)
  • Global Statins Market Analysis in Pravastatin by Geography (USD MN)
  • Global Statins Market Analysis in Simvastatin by Geography (USD MN)
  • Global Statins Market Analysis in Others by Geography (USD MN)
  • Global Statins Market Analysis by Applications (USD MN)
  • Global Statins Market Analysis in Dyslipidemia by Geography (USD MN)
  • Global Statins Market Analysis in Others by Geography (USD MN)
  • Global Statins Market Analysis by Distribution Channel (USD MN)
  • Global Statins Market Analysis in Hospitals by Geography (USD MN)
  • Global Statins Market Analysis in Clinics by Geography (USD MN)
  • Global Statins Market Analysis in Others by Geography (USD MN)
  • Global Statins Market by Geography (USD MN)
  • North America Statins Market Analysis by Type (USD MN)
  • North America Statins Market Estimate by Therapeutic Area (USD MN)
  • North America Statins Market Estimate by Drug Class (USD MN)
  • North America Statins Market Estimate by Applications (USD MN)
  • North America Statins Market Estimate by Distribution Channel (USD MN)
  • North America Statins Market Estimate by Country (USD MN)
  • United State Statins Market Analysis by Type (USD MN)
  • United State Statins Market Estimate by Therapeutic Area (USD MN)
  • United State Statins Market Analysis by Drug Class (USD MN)
  • United State Statins Market Estimate by Applications (USD MN)
  • United State Statins Market Analysis by Distribution Channel (USD MN)
  • Rest of North America Statins Market Analysis by Type (USD MN)
  • Rest of North America Statins Market Estimate by Therapeutic Area (USD MN)
  • Rest of North America Statins Market Estimate by Drug Class(USD MN)
  • Rest of North America Statins Market Estimate by Applications(USD MN)
  • Rest of North America Statins Market Estimate by Distribution Channel (USD MN)
  • Europe Statins Market Analysis by Type (USD MN)
  • Europe Statins Market Estimate by Therapeutic Area (USD MN)
  • Europe Statins Market Estimate by Drug Class (USD MN)
  • Europe Statins Market Estimate by Applications (USD MN)
  • Europe Statins Market Estimate by Distribution Channel (USD MN)
  • Europe Statins Market Estimate by Country (USD MN)
  • United Kingdom Statins Market Analysis by Type (USD MN)
  • United Kingdom Statins Market Estimate by Therapeutic Area (USD MN)
  • United Kingdom Statins Market Estimate by Drug Class (USD MN)
  • United Kingdom Statins Market Estimate by Applications (USD MN)
  • United Kingdom Statins Market Estimate by Distribution Channel (USD MN)
  • France Statins Market Analysis by Type (USD MN)
  • France Statins Market Estimate by Therapeutic Area (USD MN)
  • France Statins Market Estimate by Drug Class (USD MN)
  • France Statins Market Estimate by Applications (USD MN)
  • France Statins Market Estimate by Distribution Channel (USD MN)
  • Germany Statins Market Analysis by Type (USD MN)
  • Germany Statins Market Estimate by Therapeutic Area (USD MN)
  • Germany Statins Market Estimate by Drug Class (USD MN)
  • Germany Statins Market Estimate by Applications (USD MN)
  • Germany Statins Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Statins Market Analysis by Type (USD MN)
  • Rest of Europe Statins Market Estimate by Therapeutic Area (USD MN)
  • Rest of Europe Statins Market Estimate by Drug Class (USD MN)
  • Rest of Europe Statins Market Estimate by Applications (USD MN)
  • Rest of Europe Statins Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Statins Market Analysis by Type (USD MN)
  • Asia Pacific Statins Market Estimate by Therapeutic Area (USD MN)
  • Asia Pacific Statins Market Estimate by Drug Class (USD MN)
  • Asia Pacific Statins Market Estimate by Applications (USD MN)
  • Asia Pacific Statins Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Statins Market Estimate by Country (USD MN)
  • China Statins Market Analysis by Type (USD MN)
  • China Statins Market Estimate by Therapeutic Area (USD MN)
  • China Statins Market Estimate by Drug Class (USD MN)
  • China Statins Market Estimate by Applications (USD MN)
  • China Statins Market Estimate by Distribution Channel (USD MN)
  • Japan Statins Market Analysis by Type (USD MN)
  • Japan Statins Market Estimate by Therapeutic Area (USD MN)
  • Japan Statins Market Estimate by Drug Class (USD MN)
  • Japan Statins Market Estimate by Applications(USD MN)
  • Japan Statins Market Estimate by Distribution Channel (USD MN)
  • India Statins Market Analysis by Type (USD MN)
  • India Statins Market Estimate by Therapeutic Area (USD MN)
  • India Statins Market Estimate by Drug Class (USD MN)
  • India Statins Market Estimate by Applications (USD MN)
  • India Statins Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Statins Market Analysis by Type (USD MN)
  • Rest of Asia Pacific Statins Market Estimate by Therapeutic Area (USD MN)
  • Rest of Asia Pacific Statins Market Estimate by Drug Class (USD MN)
  • Rest of Asia Pacific Statins Market Estimate by Applications (USD MN)
  • Rest of Asia Pacific Statins Market Estimate by Distribution Channel (USD MN)
  • Latin America Statins Market Analysis by Type (USD MN)
  • Latin America Statins Market Estimate by Therapeutic Area (USD MN)
  • Latin America Statins Market Estimate by Drug Class (USD MN)
  • Latin America Statins Market Estimate by Applications (USD MN)
  • Latin America Statins Market Estimate by Distribution Channel (USD MN)
  • Latin America Statins Market Estimate by Country (USD MN)
  • Brazil Statins Market Analysis by Type (USD MN)
  • Brazil Statins Market Estimate by Therapeutic Area (USD MN)
  • Brazil Statins Market Estimate by Drug Class (USD MN)
  • Brazil Statins Market Estimate by Applications (USD MN)
  • Brazil Statins Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Statins Market Analysis by Type (USD MN)
  • Rest of Latin America Statins Market Estimate by Therapeutic Area (USD MN)
  • Rest of Latin America Statins Market Estimate by Drug Class (USD MN)
  • Rest of Latin America Statins Market Estimate by Applications (USD MN)
  • Rest of Latin America Statins Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Statins Market Analysis by Type (USD MN)
  • Middle East & Africa Statins Market Estimate by Therapeutic Area (USD MN)
  • Middle East & Africa Statins Market Estimate by Drug Class (USD MN)
  • Middle East & Africa Statins Market Estimate by Applications (USD MN)
  • Middle East & Africa Statins Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Statins Market Estimate by Country (USD MN)
  • Middle East Statins Market Analysis by Type (USD MN)
  • Middle East Statins Market Estimate by Therapeutic Area (USD MN)
  • Middle East Statins Market Estimate by Drug Class (USD MN)
  • Middle East Statins Market Estimate by Applications (USD MN)
  • Middle East Statins Market Estimate by Distribution Channel (USD MN)
  • Africa Statins Market Analysis by Type (USD MN)
  • Africa Statins Market Estimate by Therapeutic Area (USD MN)
  • Africa Statins Market Estimate by Drug Class (USD MN)
  • Africa Statins Market Estimate by Applications (USD MN)
  • Africa Statins Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Statins Report
  • Market Research Process
  • Market Research Methodology
  • Global Statins Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Applications
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Statins Market Analysis by Type (USD MN)
  • Global Statins Market Analysis in Natural Statins by Geography (USD MN)
  • Global Statins Market Analysis in Synthetic Statins by Geography (USD MN)
  • Global Statins Market Analysis by Therapeutic Area (USD MN)
  • Global Statins Market Analysis in Cardiovascular Disorders by Geography (USD MN)
  • Global Statins Market Analysis in Obesity by Geography (USD MN)
  • Global Statins Market Analysis in Inflammatory Disorders by Geography (USD MN)
  • Global Statins Market Analysis in Others by Geography (USD MN)
  • Global Statins Market Analysis by Drug Class (USD MN)
  • Global Statins Market Analysis in Atorvastatin by Geography (USD MN)
  • Global Statins Market Analysis in Fluvastatin by Geography (USD MN)
  • Global Statins Market Analysis in Lovastatin by Geography (USD MN)
  • Global Statins Market Analysis in Pravastatin by Geography (USD MN)
  • Global Statins Market Analysis in Simvastatin by Geography (USD MN)
  • Global Statins Market Analysis in Others by Geography (USD MN)
  • Global Statins Market Analysis by Applications (USD MN)
  • Global Statins Market Analysis in Dyslipidemia by Geography (USD MN)
  • Global Statins Market Analysis in Others by Geography (USD MN)
  • Global Statins Market Analysis by Distribution Channel (USD MN)
  • Global Statins Market Analysis in Hospitals by Geography (USD MN)
  • Global Statins Market Analysis in Clinics by Geography (USD MN)
  • Global Statins Market Analysis in Others by Geography (USD MN)
  • Latin America Statins Market by Revenue
  • Middle East & Africa Statins Market by Revenue
  • Recent Development in Statins Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials